The drugs on the agency’s list are those that either source all of their active pharmaceutical ingredients from China or produce finished drug products in China.
The FDA said it has been in touch with 180 drugmakers to remind them they are obligated to notify the FDA if they anticipate any disruptions in their drug supply and asked them to evaluate their supply chain.
No drugmakers have reported that they anticipate shortages due to the coronavirus, CNN reported.
China also makes a lot of medical supplies used in the U.S., such as surgical masks, respirators and surgical gowns. HHS Secretary Alex Azar told CNN that some of the $2.5 billion the White House requested from Congress to combat coronavirus will be used to buy personal protective equipment from the national stockpile, a supply of emergency drugs and other medical products managed by the government.
Read the full article here.
More articles on pharmacy:
Walgreens told consultants to erase mention of pharmacists complaints, review finds
Pharmacies need to put value over volume, Cleveland Clinic’s chief pharmacy officer says
Hormone-blocking drug is 8 times more expensive when used for kids, report finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
